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Myelination is a highly dynamic process that continues well into adulthood in humans. Several 
recent gene expression studies have found abnormal expression of genes involved in myelination 
in the prefrontal cortex of brains from patients with schizophrenia and other psychiatric illnesses. 
Defects in myelination could contribute to the pathophysiology of psychiatric illness by impairing 
information processing as a consequence of altered impulse conduction velocity and synchrony 
between cortical regions carrying out higher level cognitive functions. Myelination can be 
altered by impulse activity in axons and by environmental experience. Psychiatric illness is 
treated by psychotherapy, behavioral modiﬁ  cation, and drugs affecting neurotransmission, 
raising the possibility that myelinating glia may not only contribute to such disorders, but that 
activity-dependent effects on myelinating glia could provide one of the cellular mechanisms 
contributing to the therapeutic effects of these treatments. This review examines evidence 
showing that genes and gene networks important for myelination can be regulated by functional 
activity in axons.
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from axons (Figures 1B,D,E). Thus activity-dependent regulation 
of oligodendrocytes could contribute to cellular mechanisms pro-
moting recovery through environmental interventions and other 
non-drug treatments of psychiatric illnesses. Drug treatments for 
neuropsychiatric illnesses may also act in part through effects on 
myelinating glia. Oligodendrocytes have neurotransmitter recep-
tors for glutamate, serotonin, and dopamine, making it likely 
that antipsychotic drugs acting through these neurotransmitter 
systems would also have actions on myelinating glia that may be 
detrimental or beneﬁ  cial in psychiatric disorders. Finally, synap-
tic communication between axons and immature myelinating glia 
(oligodendrocyte progenitor cells), have been described recently in 
white matter (Karadottir et al., 2008; Kukley et al., 2007; Lin et al., 
2005), providing a rapid means of direct communication between 
axons and myelinating glia.
Myelination is a complex biological process that involves an 
intricate regulatory network among many different cell types in 
the nervous system (Rosenberg et al., 2007). Many of the genes 
revealed in genomic studies of mental illness that are crucial to 
the normal functioning of the myelination program and myelin-
maintenance are themselves candidates for regulation by electrical 
activity in axons. Many of these genes relate to oligodendroglia 
function; however some of these genes are expressed in astrocytes 
and some in neurons where they may have independent effects or 
act indirectly on myelinating glia.
TRANSCRIPTIONAL REGULATION OF MYELIN GENES IN 
OLIGODENDROCYTES
Regulating transcription of structural components of myelin, such 
as PLP1, MBP, MAG, MOG, and CNP is clearly critical in the proc-
ess of oligodendrocyte development and the subsequent correct 
myelination of speciﬁ  c axons. Several of these major components 
INTRODUCTION
The establishment and development of psychiatric disorders are 
likely to involve aberrant regulation and expression of many genes, 
together with multiple environmental factors, ultimately leading 
to illness. In recent years researchers have begun to focus on the 
potential role of white matter and oligodendrocytes in the patho-
physiology of psychiatric disorders (for a recent review see Dwork 
et al., 2007). Myelination can be viewed as a highly dynamic  process 
which can be altered by impulse activity in axons (Demerens 
et al., 1996; Stevens et al., 1998) and by environmental factors. It 
is becoming clear that myelination continues into adulthood and 
may contribute to plasticity of cognitive function, learning and 
memory (Fields, 2005, 2008). Perturbations in the molecular proc-
esses leading to axon myelination will consequently result in axon 
dysfunction and abnormal electrical conduction, therefore impair-
ing the transfer of information across brain regions. It is likely that 
axon health and dysfunction contribute to the pathophysiology of 
a number of psychiatric disorders, and axon survival is depend-
ent on the close association of axons with myelinating glia (Nave 
and Trapp, 2008). The guiding hypothesis for this review is that in 
addition to the well appreciated synaptic dysfunction in psychiatric 
disorders, oligodendrocytes also play a major role, and that myeli-
nation by oligodendrocytes well into adulthood may be regulated 
by the ﬁ  ring of action potentials in axons. This type of regulation 
may be analogous to activity-dependent changes in neurons and 
synaptic connectivity as a consequence of environmental stimuli 
(for a recent review see Fields et al., 2005).
There are several mechanisms by which oligodendrocytes could 
sense functional activity in axons (Figure 1). Oligodendrocytes at 
various stages of development have ion channels, purinergic and 
other membrane receptors that allow myelinating glia to detect 
impulse activity through the activity-dependent release of molecules 
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of myelin have been shown to be regulated by action potential  ﬁ  ring 
or by alterations in intracellular calcium or cAMP (Atkins et al., 
1997, 1999; Gao et al., 2004; Studzinski et al., 1999); both of these 
second messengers can be regulated by neural impulse activity. 
Phosphorylation of MBP is regulated by MAP kinase in response 
to action potential ﬁ  ring during long-term potentiation (LTP) in the 
hippocampus (Atkins et al., 1999), a cellular model of memory, and 
by direct electrical stimulation of white matter in hippocampus. The 
functional signiﬁ  cance of MBP phosphorylation in oligodendrocyte 
development and myelination is unclear. Additionally the level of 
mRNA and protein for MBP and PLP in an oligodendrocyte cell 
line are sensitive to increased intracellular calcium (Studzinski et al., 
1999) and myelin associated glycoprotein (MAG) is sensitive to levels 
of cAMP (Gao et al., 2004). Therefore several of the major myelin 
genes can be regulated by electrical activity or mechanisms by which 
second messenger signal transduction can be modiﬁ  ed. Many of the 
major components of myelin are deregulated in psychiatric disor-
ders, particularly in schizophrenia (Hakak et al., 2001).
In order for myelination to proceed, a complex network of tran-
scriptional repression and activation must be activated (Wegner, 
FIGURE 1 | Impulse activity in axons regulates oligodendrocyte 
development and myelination at several stages and via different signals. 
(A) Immature OPCs (NG2+ cells) in white matter on an electrically silent 
unmyelinated axon. Such cells persist in signiﬁ  cant numbers in the adult brain. 
(B) Electrical activity causes ATP release from axons, which generates 
adenosine that stimulates differentiation of NG2 cells to a mature 
oligodendrocyte, and promotes myelination (Stevens et al., 2002). K+ is released 
from electrically active axons. Blocking K+ channels in oligodendrocytes in 
culture has been shown to regulate oligodendrocyte proliferation and lineage 
progression (Ghiani et al., 1999). (C) Electrical activity can also alter the 
expression of cell adhesion molecules on the axon that are involved in initiating 
myelination (Itoh et al., 1995, 1997). This has been shown to regulate myelination 
by Schwann cells in the PNS, but the same molecule (L1-CAM) is involved in 
myelination by oligodendrocytes (Barbin et al., 2004). (D) The release of the 
neurotransmitters Glu (glutamate) or GABA from synapses formed on NG2 cells 
(Kukley et al., 2007), could provide another mechanism to regulate myelination in 
response to functional activity. (E) After NG2 cells differentiate into 
oligodendrocytes, ATP released from axons ﬁ  ring action potentials stimulates 
the synthesis and release of the cytokine LIF from astrocytes, which promotes 
myelination (Ishibashi et al., 2006). Myelination during development and 
postnatally may be regulated by several other unidentiﬁ  ed activity-dependent 
signaling molecules affecting development of oligodendrocytes and myelin 
formation. Electrical activity in axons, via the release of neurotransmitters, ions 
and ATP may inﬂ  uence gene expression in oligodendrocytes by histone 
modiﬁ  cation, RNA transport, local translation and regulate mRNA stability and 
translation by miRNAs.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  4 | 3
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2008). Several of the transcription factors required for repression 
and activation of myelin genes have been found to be abnormally 
expressed in the brains of patients with psychiatric disorders and 
in particular those with schizophrenia (Katsel et al., 2005).
Of particular interest is the transcription factor SOX10 (Tkachev 
et al., 2003) which is required for the expression of two of the major 
components of myelin, the proteins MBP and PLP1 (Stolt et al., 
2002). Recently it has been shown that in Schwann cells, the myeli-
nating glia of the peripheral nervous system, Sox10 is a component 
of a calcium-sensitive transcriptional complex (Kao et al., 2009). 
Calcium is the primary second messenger communicating action 
potential ﬁ  ring to intracellular responses (Eshete and Fields, 2001), 
and signaling to the nucleus to regulate gene transcription (Fields 
et al., 2005). The Sox10/NFAT complex is critical for Schwann cell 
development and activates several genes known to be regulators 
of myelination in the peripheral nervous system, such as KROX20 
(Kao et al., 2009). Interestingly the SOX10 gene is located in a major 
susceptibility locus for schizophrenia and reduced expression of this 
gene was found to be correlated with an increase in the methyla-
tion state of the allele found in schizophrenia patients (Iwamoto 
et al., 2005).
An increase in the methylation of chromatin is indicative of a 
transcriptionally inactive state and it will be interesting to see if 
other transcription factors and genes required for oligodendrocyte 
function are regulated in this manner. It is well established that 
epigenetic modiﬁ  cation of chromatin structure by DNA meth-
ylation is a critical event in the transcriptional regulation of gene 
expression (Kouzarides, 2007). In neurons DNA methylation can 
be affected by membrane depolarization and electrical activity in 
a Gadd45b-dependent manner (Ma et al., 2009). It is unknown if 
epigenetic regulation in oligodendrocytes can be regulated through 
a similar activity-dependent mechanism. However, the alteration of 
chromatin structure by histone deactylases (HDACs) is also thought 
to play a major role in the repression of myelin gene transcriptional 
inhibitors such as Tcf4 and Id4 (He et al., 2007a). However repres-
sion of the negative regulators of myelin gene transcription is in 
itself not sufﬁ  cient to allow immature oligodendrocytes (NG2+ 
cells) to progress to more mature developmental stage and begin 
the process of myelination (He et al., 2007b; Figure 2).
External signals generated by electrical activity in axons, such as 
ATP or glutamate release from axons, can cause changes in intra-
cellular calcium levels in oligodendrocytes and therefore these 
axonally derived signals may play a role in the epigenetic regula-
tion of the transcriptional apparatus required for lineage progres-
sion and myelination by oligodendrocytes and in the process of 
remyelination (Figure 1E). Clearly a perturbation of this type of 
epigenetic regulation in psychiatric disorders, perhaps by soluble 
axon-derived signals such as ATP or glutamate, would provide a 
link with environmental cues as axon ﬁ  ring patterns reﬂ  ect envi-
ronmental stimuli.
REGULATION OF MYELIN GENES BEYOND TRANSCRIPTION
The complexity of mRNA expression and metabolism and the 
localization of speciﬁ  c mRNAs to subcellular compartments in 
oligodendrocytes will all contribute to the eventual pool of mRNA 
available for the translational machinery. RNA transport, splic-
ing and stability mechanisms are tightly regulated by intracellu-
lar signal transduction in many cell types in the nervous system. 
FIGURE 2 | NG2+ cells and MBP+ + oligodendrocytes grown on DRG axons in 
culture. DRG axons grown in culture for 3 weeks were immunostained for 
neuroﬁ  lament (red) to identify axons and DAPI (blue) to label cell nuclei. 
(A) Immature oligodendrocyte progenitor cells (OPCs) were plated onto DRG 
axons and immunostained for the immature OPC marker NG2 (green) after 
2 days in co-culture. NG2+ positive OPCs have differentiated into multipolar cells 
with many processes contacting multiple axons in order to initiate the 
myelination process. (B) OPCs grown in co-culture with DRG axons for 7 days 
were immunostained with myelin basic protein (MBP), a component of the 
myelin sheath. Immature OPCs have differentiated into a myelination phenotype 
with expression of MBP and the formation of multiple segments of compact 
myelin associated with the axons. Scale bar = 15 µm.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  4 | 4
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Interestingly, many of the myelin genes are alternatively spliced 
during development and several of these mRNAs are targets for 
transport by speciﬁ  c RNA binding proteins (McInnes and Lauriat, 
2006). Importantly, a broad spectrum of RNA binding proteins 
has been found to be deregulated in schizophrenia (Katsel et al., 
2005), including quaking (QKI) and hnRNAPA2. Deregulation 
of such a large group of RNA binding proteins will have many 
downstream consequences for RNA metabolism and localization 
in oligodendrocytes. For example, Aberg et al. (2006) demonstrated 
that deregulation of several genes expressed in oligodendrocytes 
and associated with schizophrenia were associated with alterna-
tive expression of QKI splice variants. Therefore disruption in the 
expression of the QKI gene has downstream consequences for oli-
godendrocyte development and myelination and this may lead to 
a predisposition to psychiatric illness.
It is also known that hnRNPA2 is a carrier protein for MBP 
mRNA in oligodendrocytes (Ainger et al., 1997); it is thought that 
hnRNPA2-MBP complexes are transported into oligodendrocyte 
processes on microtubules (Carson and Barbarese, 2005), however 
the axonal signal for this mechanism is not thought to be a soluble 
factor released from the axon, but instead a cell adhesion molecule 
expressed on the axon (White et al., 2008). Nonetheless it is attrac-
tive to hypothesize that RNA metabolism beyond transcriptional 
control may also be subject to regulation by extracellular signaling 
cues derived from electrically active axons. There is evidence in the 
literature that in neuronal processes RNA transport is regulated by 
electrical activity (Willis et al., 2007). A similar type of regulation 
could in theory control RNA transport in the polarized process 
of oligodendrocytes in contact with individual axons. This type 
of regulation may provide precise control, in response to signals 
derived from electrically active axons, of the available mRNA pool 
of myelin genes in individual processes of developing and mature 
oligodendrocytes.
Another potential mechanism by which post-transcriptional 
regulation of oligodendrocyte-related genes may be accomplished 
is to regulate mRNA homeostasis by the binding of speciﬁ  c micro 
RNAs (miRNAs) to myelin gene mRNAs. Micro RNAs are regula-
tors of translation and RNA stability (Kosik and Krichevsky, 2005); 
this is achieved by miRNA binding to the UTR of target RNAs 
and directly inﬂ  uencing the amount of mRNA available to the 
translational machinery. The study of the regulation of miRNAs 
in the brain is still at a relatively early stage, however the functional 
targets of several miRNAs have been described in neurons (Fiore 
et al., 2008) and oligodendrocytes (Lau et al., 2008). Interestingly, a 
very recent study has suggested the involvement of a miRNA (miR-
219) in NMDA signaling (Kocerha et al., 2009), whereby blocking 
NMDA receptor function by regulating a CaMKII subunit that 
signals downstream of this receptor, a similar effect was seen by 
treating mice with antipsychotic medication. It is interesting to 
note that mature oligodendrocytes also express NMDA receptors 
on myelinating processes (for a recent review of glutamate signal-
ing in white matter see Bakiri et al., 2009) but the role of these 
receptors is currently unknown. Additionally Beveridge et al. (2008) 
reported that levels of another miRNA (miR-181b) are elevated in 
schizophrenia; targets of this miRNA are downregulated in the same 
brain region as the miRNA is upregulated in. Of the miRNAs known 
to function in neurons, several have been shown to be regulated 
by electrical activity in neuronal processes (for example Wayman 
et al., 2008). It is tempting to speculate that miRNA regulation of 
translation in oligodendrocytes may operate in a similar manner in 
response to soluble factors released from electrically active axons, 
such as BDNF, glutamate, ATP and GABA. Given the very early stage 
of determining functions for miRNAs in oligodendrocyte biology, 
further work is required to show the speciﬁ  c miRNAs that may 
target many of the genes implicated in oligodendrocyte function 
and are implicated in psychiatric disorders.
REGULATION OF GENES IN ASTROCYTES
In addition to oligodendrocyte-related genes, other non-neuronal 
genes such as glial ﬁ  brillary acidic protein (GFAP), an intermediate 
ﬁ  lament protein expressed in astrocytes, have been implicated in 
psychiatric disorders (Martins-de-Souza et al., 2008; Torrey et al., 
2000). Astrocytes can have an important inﬂ  uence on development 
of oligodendrocytes by secretion of trophic factors and cytokines. 
GFAP is an integral component of the astrocyte cytoskeleton and 
altered expression of GFAP can have many effects on astrocyte 
biology (Haydon, 2001). Therefore GFAP dysregulation and by 
implication astrocytic dysfunction could have profound effects on 
axon health, neuro-transmission, and neuron-glia signaling, and 
perhaps most importantly indirectly in the process of myelination. 
Additionally, GFAP expression is thought to be regulated by DNA 
methylation (Song and Ghosh, 2004) and recent evidence sug-
gests that activity in neuronal circuits can regulate the expression 
of GFAP in hippocampal cell culture (Cohen and Fields, 2008). 
Therefore extracellular factors generated by neuronal activity have 
been shown to regulate GFAP expression and astrocyte differen-
tiation and this could occur through the regulation of chromatin 
structure. Astrocytes have also been shown to have a direct role in 
regulating myelination and oligodendcrocyte development. Studies 
in cell culture have shown that astrocytes promote myelination 
in response to electrical stimulation of axons via the release of a 
cytokine Leukemia Inhibitory Factor (LIF), in response to ATP 
released from electrically active axons (Ishibashi et al., 2006). Taken 
together it is becoming clear that astrocyte function, which can be 
regulated by neuronal activity, can have profound effects on the 
myelination process and may contribute to disease progression in 
psychiatric disorders (Figure 1E).
REGULATION OF GENES IN AXONS
Another mechanism by which electrical activity could inﬂ  uence 
gene expression in oligodendrocytes is by the expression of cell 
surface signaling molecules such as speciﬁ  c cell adhesion receptors 
in axons (Figure 1C). This general type of mechanism has already 
been shown to regulate myelination in the peripheral nervous sys-
tem (Stevens et al., 1998). In these studies, different cell adhesion 
molecules on axons, NCAM, N-Cadherin, and L1-CAM were regu-
lated by speciﬁ  c frequencies of electrical stimulation (Itoh et al., 
1995, 1997). L1-CAM is required for initiation of myelination by 
Schwann cells (Wood et al., 1990) and downregulating the L1 gene 
by electrical stimulation at the appropriate frequency inhibited 
myelin formation in cell culture (Stevens et al., 1998). L1-CAM is 
also required for myelination by oligodendrocytes (Barbin et al., 
2004), suggesting that speciﬁ  c patterns of impulse activity could 
affect myelination in the brain and spinal cord.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  4 | 5
Lee and Fields  Myelin genes regulated by neural impulses
The expression of speciﬁ  c proteins and protein complexes at 
sites of axon-glia contact could provide a direct link between axon 
signaling and the regulation of gene expression in oligodendro-
cytes (Figure 1C). In support of this idea it has been demon-
strated that extracellular stimuli can regulate the localization of 
speciﬁ  c mRNAs in axons (Willis et al., 2007), and it has been 
demonstrated that the expression of cell surface receptors can 
be modulated by electrical activity in axons (Itoh et al., 1995). 
Therefore, taken together, regulation of myelination by an activ-
ity-dependent signaling cascade, originating in axons, may allow 
direct coupling of neuronal activity and oligodendrocyte intra-
cellular signaling.
In an interesting recent study by White et al. (2008) regulation of 
localized MBP translation in oligodendrocytes has been shown to 
be dependent upon the neuronal adhesion molecule L1 binding to 
oligodendrocytes resulting in Fyn-kinase activation and translation 
of MBP mRNA in oligodendrocyte processes in contact with the 
axon. This study potentially links electrical activity in axons via L1 
expression activation of Fyn-kinase, resulting in increased trans-
lation of MBP in oligodendrocyte processes. Perturbation of any 
part of this signaling mechanism could result in defective myelin. 
This type of axon-glia interaction may be a common regulatory 
mechanism by which myelin deposition is targeted to the correct 
axon site in response to the expression of a cell surface receptor by 
impulse activity in the axon.
ACTIVITY DEPENDENT REGULATION OF AXON-DERIVED 
DIFFUSIBLE MOLECULES
Importantly, it has been demonstrated that diffusible molecules 
released from axons ﬁ  ring action potentials can be detected by 
myelinating glia, with subsequent control of glial development and 
myelination. Cell culture studies have shown that action poten-
tials induced by electrical stimulation release ATP from axons, 
which activates P2 receptors on myelinating glia of the peripheral 
nervous system (Schwann cells). This regulates proliferation and 
differentiation of Schwann cells in accordance with functional 
activity in axons, by stimulating calcium inﬂ  ux, activation of 
CaMKII, MAPK, and the transcription factors c-fos, Krox24, and 
CREB (Stevens and Fields, 2000). P2 receptors are also present 
on oligodendrocyte at early stages of development (Fields and 
Burnstock, 2006). Adenosine, derived from ATP released from 
electrically active axons, acts on immature oligodendrocytes to 
promote differentiation and myelination (Stevens et  al., 2002; 
Figure 1B). Other molecules released by electrically active axons 
that could in theory inﬂ  uence myelinating glia include potassium 
(K+) and neurotransmitters. Several studies have demonstrated that 
blockade of K+ channels or membrane depolarization with veratri-
dine inhibits oligodendrocyte cell proliferation and differentiation 
(Ghiani et al., 1999). Growth factors, such as BDNF, which are 
known regulators of oligodendrocyte differentiation (Van’t Veer 
et al., 2009), can be secreted or regulated in an activity-depend-
ent manner and by environmental experience, providing another 
potential general mechanism for activity-dependent regulation of 
myelination. Interactions between BDNF and serotonin in mood 
disorders have been reported (Martinowich and Lu, 2008), and the 
BDNF gene has been associated with increased risk for a number 
of neuropsychiatric disorders (Martinowich et al., 2007).
REGULATION OF GENE EXPRESSION AND 
PHARMACOLOGICAL INTERVENTION IN PSYCHIATRIC 
DISORDERS
Drug treatments for psychiatric disorders that correct deregulation 
of genes involved in myelination and oligodendrocyte dysfunction 
are an appealing possibility. In this regard pharmacological regu-
lation of the activity of speciﬁ  c histone deacetylases (HDACs) is 
an interesting avenue of investigation, although therapeutic inter-
vention of the modulation of HDAC activity in mouse models 
of demyelination has shown mixed results. Therefore it may be 
important to identify cell-type speciﬁ  c regulators of chromatin 
structure as it relates to oligodendrocyte function, thus targeting 
any drug treatments more speciﬁ  cally to limit off-target effects on 
other cell populations in the brain. Regulation of gene expression by 
medication beyond transcriptional regulation may provide a more 
speciﬁ  c mechanism to target myelin genes in oligodendrocytes. 
In this regard a very interesting piece of preliminary data comes 
from the study by Aberg et al. (2006) who show that the level of 
QKI mRNA can be inﬂ  uenced by medication used to treat schizo-
phrenic patients. Modulation of QKI levels would have effects on 
the mRNA levels and cellular localization of many of the myelin 
genes and therefore oligodendrocyte function in the process of 
myelination. This research is at an early stage; however it opens up 
new routes that may be used to correct the defects seen in myelin 
gene expression in oligodendrocytes.
A recent study (Roy et al., 2007) implicates erb-signaling in 
oligodendrocytes in the functioning of dopaminergic neurons. 
Erb4 and its ligand neuregulin have been linked genetically to 
several psychiatric disorders (Corfas et  al., 2004). This ﬁ  nd-
ing is perhaps of great clinical relevance as many antipsychotic 
medications work through modulation of dopamine. It is cur-
rently unclear exactly how dopamine function is disrupted by 
oligodendrocyte dysfunction; however this ﬁ  nding provides yet 
another link between oligodendrocyte biology and the correct 
functioning of neurons.
The extent to which dopamine levels could lead to mental 
illness in part through effects on myelinating glia, and whether 
antipsychotic treatments have therapeutic action in part through 
effects on oligodendrocytes are two intriguing questions of cur-
rent investigation. There is evidence that dopamine can inﬂ  u-
ence oligodendrocyte development and function. Both D2 and 
D3 dopamine receptors are expressed in oligodendrocytes or oli-
godendrocyte progenitors (Bongarzone et al., 1998; Howard et al., 
1998). Quetiapine, a D2 receptor agonist used as an antipsychotic 
drug, increases synthesis of myelin basic protein and facilitates 
myelination in rat embryonic cortical cultures (Xiao et al., 2008). 
The D2/D3 agonist quinpirole also increases the number of oli-
godendrocyte progenitor cells (OPCs) and it decreases the number 
of mature oligodendrocytes in primary cell culture. Dopamine 
also can be toxic to oligodendrocyte progenitors by inducing 
superoxide generation and lowering glutathione levels (Hemdan 
and Almazan, 2008). Agonists for dopamine D2 and D3 recep-
tors have been shown to provide signiﬁ  cant protection of oli-
godendrocytes against oxidative injury (Rosin et al., 2005). On 
the contrary, haloperidol, a typical antipsychotic drug blocking 
D2 activity reduces myelin proteins in mice treated for 30 days 
(Narayan et al., 2007).Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  4 | 6
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Schizophrenia and depression can also involve imbalances in 
the neurotransmitter serotonin, and several drug treatments act 
through regulating serotonin levels, for example the serotonin 
reuptake inhibitor ﬂ  uoxetine (PROZAC). Serotonin receptors are 
expressed in Schwann cells (Gaietta et al., 2003), the myelinat-
ing glia of the PNS, and the human polymavirus, JC virus, which 
causes multifocal leukoencaphalopathy, binds the 5HT2a serot-
onin receptor (Elphick et al., 2004) on oligodendrocyte progenitor 
cells (Schaumburg et al., 2008). The serotonin antagonists, meto-
clopramidine, chlorpromazine, clozapine, and serotonin itself all 
signiﬁ  cantly inhibit viral infection (Elphick et al., 2004), which 
indicates that medications affecting serotonin levels could inﬂ  u-
ence oligodendrocytes. Indeed, the antidepressant drug, ﬂ  uoxetine, 
increases cell proliferation of precursors in cell culture that can 
give rise to astrocytes, neurons, or oligodendrocytes (Zusso et al., 
2004). Serotonin injection into the CNS of dogs has long been 
known to cause severe demyelination (Saakov et al., 1977), and 
serotonin reduces the number of oligodendrocytes in adult mouse 
brain (Moller, 2007).
Other neurotransmitters can regulate different steps of oli-
godendrogliogenesis through such ion channels and receptors as 
the delayed K+ rectiﬁ  er, the AMPA/kainate, dopamine or muscarinic 
receptors (review see Belachew et al., 1999). This suggests the pos-
sibility for activity-dependent regulation of oligodendrocyte differ-
entiation and myelination, and raises the possibility of medications 
acting on neurotransmitters or the excitation of speciﬁ  c circuits 
could inﬂ  uence oligodendrocytes.
CONCLUSIONS AND FUTURE WORK
Evidence from multiple areas of research including human brain 
imaging studies and large scale mRNA proﬁ  ling analyses strongly 
indicate that defects in myelin and abnormal expression of mye-
lin genes, and their regulators, are common in many psychiatric 
disorders. It is plausible that perturbations in axon conductance 
brought about by defects in myelin are responsible for many of 
the cognitive impairments seen in psychiatric disorders. It is also 
clear that oligodendrocyte development and myelination and the 
process of remyelination involve a complex network of intracellular 
modiﬁ  cation and extracellular signaling cues. It is apparent that 
activity in axons can not only regulate gene expression in the axon, 
but may also in turn regulate gene expression in oligodendrocytes. 
Therefore the identiﬁ  cation of signaling cues generated by axons 
ﬁ  ring action potentials, which may be responsible for regulating 
gene expression in oligodendrocytes, is likely to be an important 
area for future research.
The situation is complex as both positive and negative regu-
lators of oligodendrocyte function will be involved, and growth 
factors, cytokines, and neurotransmitters can have pronounced 
dose-dependent effects that may stimulate or inhibit oligodendro-
cyte development. Research thus far has identiﬁ  ed three molecular 
mechanisms regulating myelination by action potentials in axons: 
(1) adenosine derived from ATP released from electrically active 
axons stimulates differentiation of OPCs (Stevens et al., 2002); (2) 
after oligodendrocytes mature, ATP released from axons acts on 
astrocytes to stimulate the synthesis and release of LIF which pro-
motes myelination (Ishibashi et al., 2006); (3) action potentials at 
appropriate frequencies down regulate the cell adhesion molecule 
L1-CAM to inhibit myelination (Stevens et al., 1998).
Many other soluble factors released from axons ﬁ  ring action 
potentials, in addition to ATP and adenosine, are potential can-
didates for regulating myelination, such as GABA, glutamate, and 
nitric oxide; growth factors, such as BDNF, or enzymes that are 
able to modify protein complexes expressed on the surface of oli-
godendrocyte processes, are also likely to be involved in activity-
dependent myelination. Changes in speciﬁ  c complexes of proteins 
expressed on axons in response to ﬁ  ring patterns, notably cell adhe-
sion molecules and other membrane receptors, is another general 
mechanism regulating oligodendrocyte development and myelina-
tion to neural impulse activity. It is likely that a combination of 
all these intercellular communication pathways, and multiple cell 
types, are at work regulating myelinating glia in the mammalian 
brain in accordance with functional activity in individual axons in 
neural circuits mediating cognitive function.
Researchers are only beginning to develop an understanding 
of how electrical activity can regulate myelin formation. Even less 
is known about axon-derived soluble factors and their possible 
role in regulating other aspects of oligodendrocyte biology, such 
as cell polarity and vesicle trafﬁ  cking. It is still unclear if the myelin 
abnormalities seen in psychiatric disorders are the cause of axon 
dysfunction or a consequence of it, but there is strong evidence to 
suggest both processes are at work. Effects of drugs that are used 
in treating psychiatric illnesses on myelinating glia, suggest that 
some of the beneﬁ  cial action could be mediated through effects 
on oligodendrocytes, and conversely, that the cellular changes in 
white matter seen in schizophrenia, chronic depression, and other 
psychiatric illnesses could be induced in part by the treatments. 
Only a much clearer understanding of the complex relationship 
between myelinating oligodendrocytes and axons (Figures 1 and 2) 
will allow novel therapies to be developed in the treatment of myelin 
dysfunction and psychiatric disease.
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